The MS subgroup is characterized as having an elevated expression of epithelial-to-mesenchymal-transition (EMT) associated genes, such as DES and TWIST, and mesenchymal cell-related genes, including VIM (vimentin), MMPs, PDGFRA, and PDGFRB (Walter et al., 2013; The Cancer Genome Atlas Network [TCGA], 2015). This evidence concerns the gene VIM and myeloid sarcoma.